XB-ART-55599
Nat Commun
2018 Aug 06;91:3075. doi: 10.1038/s41467-018-05446-4.
Show Gene links
Show Anatomy links
Calcium is an essential cofactor for metal efflux by the ferroportin transporter family.
Deshpande CN
,
Ruwe TA
,
Shawki A
,
Xin V
,
Vieth KR
,
Valore EV
,
Qiao B
,
Ganz T
,
Nemeth E
,
Mackenzie B
,
Jormakka M
.
???displayArticle.abstract???
Ferroportin (Fpn)-the only known cellular iron exporter-transports dietary and recycled iron into the blood plasma, and transfers iron across the placenta. Despite its central role in iron metabolism, our molecular understanding of Fpn-mediated iron efflux remains incomplete. Here, we report that Ca2+ is required for human Fpn transport activity. Whereas iron efflux is stimulated by extracellular Ca2+ in the physiological range, Ca2+ is not transported. We determine the crystal structure of a Ca2+-bound BbFpn, a prokaryotic orthologue, and find that Ca2+ is a cofactor that facilitates a conformational change critical to the transport cycle. We also identify a substrate pocket accommodating a divalent transition metal complexed with a chelator. These findings support a model of iron export by Fpn and suggest a link between plasma calcium and iron homeostasis.
???displayArticle.pubmedLink??? 30082682
???displayArticle.pmcLink??? PMC6079014
???displayArticle.link??? Nat Commun
???displayArticle.grants??? [+]
R01 DK080047 NIDDK NIH HHS , R01 DK107309 U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases), R01 DK082717 NIDDK NIH HHS , P30 DK078392 NIDDK NIH HHS , R01 DK107309 NIDDK NIH HHS
???attribute.lit??? ???displayArticles.show???
Fig. 1. Calcium activates Fpn-mediated iron efflux in Xenopus oocytes. a First-order rate constants (k) for 55Fe efflux from control oocytes and oocytes expressing human Fpn, in the presence (+Na+o) or absence (−Na+o) of 100 mM extracellular Na+; n = 10, 14, 16, 17 oocytes per group (left to right). Two-way ANOVA revealed no interaction (P = 0.86); within Fpn, +Na+o did not differ from −Na+o (P = 0.73). b 55Fe efflux from control oocytes and oocytes expressing human Fpn in the presence of 2 mM extracellular Ca2+ or in its absence (i.e. 0 mM Ca2+ plus 1 mM EGTA) (n = 16, 16, 15, 16). Two-way ANOVA: interaction (P < 0.001). c 55Fe efflux from control oocytes (red) and oocytes expressing Fpn (black) as a function of [Ca2+]o (control, n = 30; Fpn, n = 84; i.e. 6–9 oocytes per group at each [Ca2+]o). Fpn data were fit by Eq. (2): \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$K_{0.5}^{{\mathrm{Ca}}}$$\end{document}K0.5Ca = 0.8 ± (SEM) 0.2 mM, Vmax occurred at k = (16 ± 2) × 10−3 min−1 (r2 = 0.88, P < 0.001). d 57Co efflux from control oocytes and oocytes expressing Fpn in the presence of 2 mM extracellular Ca2+ or in its absence (i.e. 0 mM Ca2+ plus 1 mM EGTA) (n = 7, 7, 6, 6). Two-way ANOVA: interaction (P < 0.001). e 65Zn efflux from control oocytes and oocytes expressing Fpn injected with 50 nl of 50 µM 65Zn in the presence of 2 mM extracellular Ca2+ or in its absence (i.e. 0 mM Ca2+ plus 1 mM EGTA) (n = 19, 21, 20, 19). Two-way ANOVA: interaction (P < 0.001). f 63Ni efflux from control oocytes and oocytes expressing Fpn in the presence of 2 mM extracellular Ca2+ or in its absence (i.e. 0 mM Ca2+ plus 1 mM EGTA) (n = 10, 9, 12, 12). Two-way ANOVA: interaction (P < 0.001). All bar graphs indicate mean, SD, and individual scores; data in (c) are mean, SD | |
Fig. 2. Alkaline-earth metal selectivity. a 55Fe efflux from control oocytes and oocytes expressing Fpn, in the presence of extracellular calcium (2 mM) and magnesium (1 mM), the absence of extracellular calcium (–Ca2+oi.e. 0 mM Ca2+ plus 1 mM EGTA), or the absence of extracellular magnesium (–Mg2+o)i.e. 0 mM Mg2+ plus 1 mM EDTA) (n = 12 in each group). Two-way ANOVA: interaction (P < 0.001); within Fpn, all groups differ from one another (P ≤ 0.004). b 55Fe efflux from control oocytes and oocytes expressing Fpn in the presence of 3 mM extracellular magnesium (+Mg2+), or 1 mM Mg2+ plus 2 mM calcium (+Ca2+), strontium (+Sr2+), or barium (+Ba2+) (n = 30, 39, 28, 32, 27, 36, 25, 32). Two-way ANOVA: interaction (P < 0.001). In multiple pairwise comparisons vs. control: Fpn differed from control in the case of Ca2+ and Sr2+ (P < 0.001), but not Mg2+ (P = 0.14) or Ba2+ (P = 0.082); within Fpn, all conditions differed from ‘+Ca2+’ (P < 0.001). Bar graphs indicate mean, SD, and individual scores | |
Fig. 3. No evidence to support that calcium is a transported substrate of Fpn. a Uptake of 100 μM 45Ca2+ in control oocytes and oocytes expressing Fpn that were injected with either vehicle alone (−Fei) or 50 nl of 50 µM Fe (+Fei) (n = 12, 12, 13, 14, left to right). Two-way ANOVA: no interaction (P = 0.70). b Uptake of 100 μM 45Ca2+ in control oocytes and oocytes expressing Fpn in the absence of extracellular Na+ (Na+ was replaced by choline) (n = 12, 8, 11, 12). Oocytes were injected with either vehicle alone (−Fei) or 50 nl of 50 µM Fe (+Fei). Two-way ANOVA: interaction (P = 0.008); within Fpn, +Fei did not differ from −Fei (P = 0.069). c Effect of 1 µM ionomycin (IMN) or 2 µM thapsigargin (THG) on 55Fe efflux (n = 15, 14, 14, 16, 15, 14). All media contained 0.2% DMSO. Two-way ANOVA: no interaction (P = 0.13). d Efflux of 55Fe or 45Ca efflux from control oocytes and oocytes expressing Fpn (n = 11, 12, 9, 10). Two-way ANOVA: interaction (P < 0.001); within 45Ca, Fpn did not differ from control (P = 0.98). All bar graphs indicate mean, SD, and individual scores | |
Fig. 4. Calcium activates Fpn-mediated iron efflux in a HEK cell expression system. HEK293T cells expressing Fpn were loaded with 55Fe, and 55Fe efflux measured in media containing 1 mM Ca2+ (black) or 0 Ca2+ +1 mM EGTA (green). Data, normalized by 55Fe content at time = 0, are displayed as induced minus uninduced in the same preparation. Each symbol-and-line plot represents one of four independent preparations. Two-way RM ANOVA: interaction of [Ca2+]o and time (P < 0.001); Ca2+ significantly activated 55Fe efflux over 6 h (P = 0.002) and 24 h (P < 0.001), but not at earlier time points (P ≥ 0.24) | |
Fig. 5. Crystal structure of a Ca2+-bound BbFpn reveals a conserved binding site. a Overall structure of the Ca2+ -bound inward facing conformation of BbFpn and close up view of the Ca2+ site (right). Approximate location of the membrane bilayer is illustrated with red (outside) and blue (inside) dots, generated using the PPM server41. TM7 is highlighted in orange. The Ca2+ ion is colored in green, and coordinating residues are shown in ball-and-stick. Some of the distances are longer than the reported ideal Ca2+–O distance (~2.5 Å)42, although this is not unprecedented considering the resolution of the structure17. b Intracellular view (left) and Fo–Fc omit map of the Ca site (right; contoured at 5.5σ). c, d Binding of the Ca2+ ion leads to a kink forming in TM6, likely promoted by the Ca2+ coordinating N196 and E203. e Representative ITC experiment between wild type BbFpn/Ca2+. Stoichiometry (N) and dissociation constant (Kd) of each interaction are indicated. The variations in free energy (ΔG), enthalpy (ΔH), and entropy (−TΔS) are respectively, in blue, green, and red in the histogram | |
Fig. 6. Mutagenesis of putative Ca2+-coordinating residues in human Fpn. a 55Fe efflux from control oocytes and oocytes expressing wildtype or mutant Fpn in media containing 2 or 20 mM Ca2+ (n = 77, 54, 96, 69, 37, 35, 37, 35, 56, 39, 34, 29, left to right). Two-way ANOVA: interaction, P < 0.001; Q99A and N212Q differed from control (P < 0.001) but D39E and E219D did not differ from control (P ≥ 0.78). Raising [Ca2+]o from 2 to 20 mM increased 55Fe efflux for Q99A and N212Q (P ≤ 0.001) but not for any other mutant (P ≥ 0.61). Relative expression levels were estimated from GFP fluorescence (Supplementary Fig. 7A). b 55Fe efflux from control oocytes (red, n = 22) and oocytes expressing wildtype Fpn (black, n = 62) or Q99A (blue, n = 76) as a function of [Ca2+]o (i.e. 6–9 oocytes at each concentration). Data were fit by Eq. (2): wildtype Fpn, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$K_{0.5}^{{\mathrm{Ca}}}$$\end{document}K0.5Ca = 0.9 ± (SEM) 0.1 mM, Vmax occurred at k = (24 ± 1) × 10−3 min−1 (r2 = 0.97, P < 0.001); and Q99A, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$K_{0.5}^{{\mathrm{Ca}}}$$\end{document}K0.5Ca = 2.4 ± 0.4 mM, Vmax occurred at k = (20 ± 1) × 10−3 min−1 (r2 = 0.83, P < 0.001). c 55Fe efflux from control oocytes and oocytes expressing wildtype or mutant Fpn (n = 12, 11, 12, 12, 11, 12, 12, 10). Two-way ANOVA: interaction, P = 0.009; neither mutant differed from control at either 2 or 20 mM Ca2+ (P ≥ 0.76). Raising [Ca2+]o from 2 to 20 mM increased 55Fe efflux for wildtype Fpn (P < 0.001) but not for either mutant (P ≥ 0.73). All bar graphs indicate mean, SD, and individual scores; data in b are mean, SD | |
Fig. 7. Putative substrate-binding site located in the C-terminal domain. a Surface representation of the C-terminal domain of BbFpn, viewed from the central cavity. The pocket formed by the non-continuous TM7 is in the center of the domain, with the Ni-EDTA molecule shown in ball-and-stick. Insets show Fo–Fc omit (top) and 2Fo–Fc map (bottom) of the Ni-EDTA site. b Close-up view of the Ni-EDTA-binding site and coordination. Main hydrogen bonds are indicated by dotted lines. R348 forms a salt-bridge to one of the carboxylate groups of the EDTA moiety, shown in yellow, whereas H261 is a direct ligand to the metal (green sphere). c Superposition of the Ni-EDTA bound structure and the previously determined open inward conformation (gray; PDB entry 5AYO) illustrating conformational change of H261. d Effects of mutating residues within the putative metal-binding site of human Fpn. 55Fe efflux (black) and 63Ni efflux (green) from control oocytes and oocytes expressing wtFpn or one of several amino-acid substitutions at residue D325 (n = 24, 29, 32, 26, 30, 22, 28, 35, 33, 35, left to right). The bar graph indicates mean, SD, and individual scores. Two-way ANOVA revealed an interaction (P < 0.001). Within 55Fe efflux, each mutant differed from wtFpn (P < 0.001); and D325N (P < 0.001) but neither D325A (P = 0.78) nor D325H (P = 0.025) differed from control. Within 63Ni, all groups differed from control (P < 0.001); D325A and D325H differed from wtFpn (P < 0.001) but D325N did not differ from wtFpn (P = 0.14). e–g Working model to illustrate Ca2+-activated Fpn-mediated iron efflux |
References [+] :
Abramson,
Structure and mechanism of the lactose permease of Escherichia coli.
2003, Pubmed
Abramson, Structure and mechanism of the lactose permease of Escherichia coli. 2003, Pubmed
Adams, PHENIX: a comprehensive Python-based system for macromolecular structure solution. 2010, Pubmed
Aschemeyer, Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. 2018, Pubmed , Xenbase
Bonaccorsi di Patti, A bacterial homologue of the human iron exporter ferroportin. 2015, Pubmed
Bushinsky, Electrolyte quintet: Calcium. 1998, Pubmed
Carugo, How many water molecules can be detected by protein crystallography? 1999, Pubmed
Cherezov, Lipidic cubic phase technologies for membrane protein structural studies. 2011, Pubmed
Crielaard, Targeting iron metabolism in drug discovery and delivery. 2017, Pubmed
Donovan, The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. 2005, Pubmed
Drakesmith, Ironing out Ferroportin. 2015, Pubmed
Drew, A scalable, GFP-based pipeline for membrane protein overexpression screening and purification. 2005, Pubmed
Egi, Ionized calcium concentration and outcome in critical illness. 2011, Pubmed
Emsley, Features and development of Coot. 2010, Pubmed
Ethayathulla, Structure-based mechanism for Na(+)/melibiose symport by MelB. 2014, Pubmed
Faham, The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport. 2008, Pubmed
Forrest, The structural basis of secondary active transport mechanisms. 2011, Pubmed
Ganz, Systemic iron homeostasis. 2013, Pubmed
Gouaux, Principles of selective ion transport in channels and pumps. 2005, Pubmed
Hentze, Two to tango: regulation of Mammalian iron metabolism. 2010, Pubmed
Johnson, Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å. 2012, Pubmed
Kabsch, XDS. 2010, Pubmed
Krishnamurthy, Unlocking the molecular secrets of sodium-coupled transporters. 2009, Pubmed
Krom, Complementary metal ion specificity of the metal-citrate transporters CitM and CitH of Bacillus subtilis. 2000, Pubmed
Lensbouer, Functional characterization and metal ion specificity of the metal-citrate complex transporter from Streptomyces coelicolor. 2008, Pubmed
Lepsík, Binding of calcium and other metal ions to the EF-hand loops of calmodulin studied by quantum chemical calculations and molecular dynamics simulations. 2007, Pubmed
Li, Protonation, tautomerization, and rotameric structure of histidine: a comprehensive study by magic-angle-spinning solid-state NMR. 2011, Pubmed
Lomize, OPM database and PPM web server: resources for positioning of proteins in membranes. 2012, Pubmed
McCoy, Phaser crystallographic software. 2007, Pubmed
Miroux, Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. 1996, Pubmed
Mitchell, Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. 2014, Pubmed , Xenbase
Nemeth, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. 2004, Pubmed
Nomura, Structure and mechanism of the mammalian fructose transporter GLUT5. 2015, Pubmed
Quistgaard, Understanding transport by the major facilitator superfamily (MFS): structures pave the way. 2016, Pubmed
Ruchala, The pathophysiology and pharmacology of hepcidin. 2014, Pubmed
Sandier, A study of strontium binding to albumins, by a chromatographic method involving atomic emission spectrometric detection. 1999, Pubmed
Taniguchi, Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin. 2015, Pubmed
Yan, Structural advances for the major facilitator superfamily (MFS) transporters. 2013, Pubmed
Yang, Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe. 2012, Pubmed
Zheng, Data mining of metal ion environments present in protein structures. 2008, Pubmed